Table 1 Characteristics of TANEC infants.
 | TANEC (N = 149) | No-NEC (N = 15,213) | UNTA-NEC (N = 795) | P values | |
---|---|---|---|---|---|
TANEC vs No-NEC | TANEC vs UNTA-NEC | ||||
Maternal age (median, IQR) | 30 (28–34) | 31 (28–34) | 31 (28–34) | 0.587 | 0.905 |
Cesarean delivery (n, %) | 78/149 (52.4) | 8900/15,167 (59.7) | 482/794 (60.7) | 0.119 | 0.057 |
Gestational age, weeks (median, IQR) | 28.9(27.1–30.4) | 29.4(28–30.9) | 29.9 (28.3–31) | 0.003 |  < 0.001 |
Gestational age weeks (n, %) | |||||
 < 26 | 14/149 (9.4) | 945/15,213 (6.2) | 47/795(5.9) | 0.043 | 0.052 |
 26–28 | 43/149 (28.9) | 3137/15,213 (20.) | 130/795(16.4) | 0.017 |  < 0.001 |
 29–30 | 45/149 (30.2) | 5545/15,213 (36.5) | 286/795 (36.0) | 0.518 | 0.543 |
 30–32 | 43/149 (28.9) | 4570/15,213 (30.0) | 274/795 (34.5) | 0.828 | 0.538 |
 > 32 | 4/149(2.7) | 1016/15,213 (6.7) | 58/795 (7.3) |  |  |
Birth weight, grams (median, IQR) | 1140 (950–1310) | 1200 (1004–1400) | 1240 (1030–1450) | 0.001 |  < 0.001 |
Birth weight, grams (n, %) | |||||
 < 1000 | 47/149 (31.5) | 3343/15,213(22.0) | 160/795 (20.1) | 0.002 |  < 0.001 |
 1000–1500 | 87/149 (58.4) | 9453/15,213 (62.1) | 482/795 (60.6) | 0.936 | 0.754 |
 ≥ 1500 | 15/149 (10.1) | 2417/15,213 (15.9) | 153/795 (19.3) |  |  |
Male gender (n, %) | 84/149 (56.4) | 8597/15,207 (56.5) | 464/794 (58.4) | 0.984 | 0.697 |
SGA (n, %) | 23/149 (15.4) | 2270/15,133 (15.0) | 127/794 (16.0) | 0.881 | 0.866 |
Inborn (n, %) | 103/149 (69.1) | 9392/15,213 (61.7) | 474/795 (59.6) | 0.066 | 0.030 |
Placental transfusion (n, %) | 59/149 (39.6) | 4547/15,213 (29.9) | 276/795 (34.7) | 0.011 | 0.254 |
Endotracheal incubation during resuscitation (n, %) | 54/149 (36.2) | 4876/15,213 (32.1) | 176/795 (22.1) | 0.276 |  < 0.001 |
Low 5-min Apgar score (n %) | 35/149 (23.5) | 3367/15,213 (22.1) | 122/795 (15.4) | 0.691 | 0.014 |
Age at first feed in days ≤ 3 (n, %) | 110/149 (73.8) | 9862/15,213 (64.8) | 494/795 (62.1) | 0.023 | 0.006 |
Duration of antibiotic therapy in 1st 7 days of life in days > 4 (n, %) | 101/149 (67.8) | 9888/15,213 (65.0) | 443/795 (55.7) | 0.478 | 0.007 |
PDA (n %) | 86/149 (58.5) | 7352/15,213 (49.3) | 396/795 (49.8) | 0.026 | 0.083 |
PDA (required treatment) (n %) | 39/149 (26.2) | 3013/15,213 (19.8) | 160/795 (20.1) | 0.057 | 0.101 |